Skip to Content

Apomorphine Pregnancy and Breastfeeding Warnings

Apomorphine is also known as: APO-Go, APO-Go Pen, Apokyn, Uprima

Medically reviewed on May 22, 2017

Apomorphine Pregnancy Warnings

Apomorphine has been assigned to pregnancy category C by the FDA. Animal reproduction studies have not been conducted with apomorphine. There are no controlled data from human pregnancy studies. It is also not known whether apomorphine can cause fetal harm when administered to a pregnant woman. Apomorphine should only be given during pregnancy when benefit outweighs risk.

See references

Apomorphine Breastfeeding Warnings

There are no data on the excretion of apomorphine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Apokyn (apomorphine)." Mylan Pharmaceuticals Inc, Morgantown, WV.

References for breastfeeding information

  1. "Product Information. Apokyn (apomorphine)." Mylan Pharmaceuticals Inc, Morgantown, WV.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide